Clinicians' attitudes toward general screening of the ashkenazi-jewish population for prevalent founder BRCA1/2 and LRRK2 mutations

S. Shkedi-Rafid, G. Ofer-Bialer, V. Meiner, R. Calderon-Margalit

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Aims: Advances in genomics may eventually lead to genetic susceptibility screening of the general population, regardless of a personal or familial history of the disease in question. Yet, little is known about clinicians' attitudes toward such programs. We explored attitudes of family practitioners, medical geneticists and genetic counselors toward genetic screening of the general Ashkenazi-Jewish population for the common founder mutations in BRCA1/2 and LRRK2 genes (which increase the risk of hereditary breast/ovarian cancers and Parkinson's disease, respectively). Methods: Participants (n = 204) completed a specially designed questionnaire, distributed by e-mail, regular mail or in-person. Results: Slightly more than half (52%) were in favor of BRCA screening, while the vast majority (86%) opposed to LRRK2 screening. About two-thirds (68%) of the respondents supported pre-test genetic counseling. Attitudes were largely independent of professional background and sociodemographic characteristics, though a correlation was found with personal interest in genetic self-testing for the above genes. Adverse psychological impact and discrimination in insurance and employment were the major concerns cited by respondents with regard to screening programs. Conclusion: Our findings suggest that the availability of measures for prevention and/or treatment is a major factor in the attitudes of healthcare providers toward population screening for late-onset conditions.

Original languageAmerican English
Pages (from-to)174-183
Number of pages10
JournalPublic Health Genomics
Issue number4
StatePublished - 2013

Bibliographical note

Publisher Copyright:
Copyright © 2013 S. Karger AG, Basel.


  • Ashkenazi Jews
  • Genetic screening
  • Healthcare providers
  • Hereditary breast/ovarian cancer
  • Parkinson's disease


Dive into the research topics of 'Clinicians' attitudes toward general screening of the ashkenazi-jewish population for prevalent founder BRCA1/2 and LRRK2 mutations'. Together they form a unique fingerprint.

Cite this